 Zhiying You
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 8 | 2021 | 189 | 1.340 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2020 | 467 | 0.850 |
Why?
| | Acute Kidney Injury | 6 | 2021 | 613 | 0.790 |
Why?
| | Endothelium, Vascular | 6 | 2021 | 973 | 0.720 |
Why?
| | Vascular Stiffness | 4 | 2021 | 379 | 0.630 |
Why?
| | Kidney | 9 | 2021 | 1211 | 0.600 |
Why?
| | Kidney Failure, Chronic | 5 | 2020 | 441 | 0.560 |
Why?
| | Glomerular Filtration Rate | 10 | 2021 | 575 | 0.510 |
Why?
| | Hypertension | 5 | 2021 | 1185 | 0.460 |
Why?
| | Blood Pressure | 5 | 2021 | 1761 | 0.440 |
Why?
| | Fibroblast Growth Factors | 3 | 2020 | 176 | 0.400 |
Why?
| | Complement System Proteins | 3 | 2021 | 271 | 0.390 |
Why?
| | Brachial Artery | 3 | 2020 | 194 | 0.380 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 2 | 2018 | 13 | 0.370 |
Why?
| | Creatinine | 2 | 2020 | 461 | 0.350 |
Why?
| | Sodium | 2 | 2019 | 204 | 0.350 |
Why?
| | Kidney Transplantation | 4 | 2019 | 382 | 0.350 |
Why?
| | Vasodilation | 3 | 2020 | 476 | 0.330 |
Why?
| | Endothelial Cells | 3 | 2021 | 650 | 0.320 |
Why?
| | Uric Acid | 2 | 2021 | 353 | 0.320 |
Why?
| | Critical Illness | 2 | 2021 | 584 | 0.290 |
Why?
| | Renal Dialysis | 2 | 2019 | 329 | 0.280 |
Why?
| | Cognition | 3 | 2018 | 964 | 0.270 |
Why?
| | Cognitive Dysfunction | 2 | 2018 | 249 | 0.270 |
Why?
| | Double-Blind Method | 7 | 2021 | 1673 | 0.250 |
Why?
| | Pregnancy Complications | 2 | 2018 | 483 | 0.240 |
Why?
| | Complement Pathway, Classical | 1 | 2021 | 19 | 0.230 |
Why?
| | Curcumin | 1 | 2021 | 32 | 0.230 |
Why?
| | Nephrotic Syndrome | 1 | 2021 | 26 | 0.230 |
Why?
| | Breathing Exercises | 1 | 2021 | 21 | 0.230 |
Why?
| | Middle Aged | 21 | 2021 | 28753 | 0.230 |
Why?
| | Nephrosis, Lipoid | 1 | 2021 | 28 | 0.230 |
Why?
| | Respiratory Muscles | 1 | 2021 | 32 | 0.230 |
Why?
| | Inhalation | 1 | 2021 | 30 | 0.230 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2021 | 38 | 0.220 |
Why?
| | Cardiolipins | 1 | 2021 | 73 | 0.220 |
Why?
| | Kidney Glomerulus | 1 | 2021 | 122 | 0.220 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2021 | 91 | 0.220 |
Why?
| | Male | 29 | 2021 | 60993 | 0.220 |
Why?
| | Aged | 17 | 2021 | 20109 | 0.220 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2020 | 38 | 0.210 |
Why?
| | Bicarbonates | 1 | 2020 | 46 | 0.210 |
Why?
| | Immunoglobulin M | 1 | 2021 | 239 | 0.210 |
Why?
| | Bone Diseases | 1 | 2020 | 52 | 0.210 |
Why?
| | Allopurinol | 2 | 2018 | 88 | 0.200 |
Why?
| | Female | 28 | 2021 | 63035 | 0.200 |
Why?
| | Lipocalins | 1 | 2019 | 39 | 0.200 |
Why?
| | Prospective Studies | 9 | 2021 | 6250 | 0.200 |
Why?
| | Frailty | 1 | 2020 | 57 | 0.200 |
Why?
| | Antigen-Antibody Complex | 1 | 2019 | 95 | 0.200 |
Why?
| | Complement C3d | 1 | 2019 | 68 | 0.200 |
Why?
| | Epitopes | 1 | 2021 | 430 | 0.200 |
Why?
| | Vascular System Injuries | 1 | 2019 | 56 | 0.190 |
Why?
| | Vascular Diseases | 1 | 2021 | 227 | 0.190 |
Why?
| | Spironolactone | 1 | 2019 | 37 | 0.190 |
Why?
| | Renal Replacement Therapy | 1 | 2019 | 59 | 0.190 |
Why?
| | Biomarkers | 8 | 2021 | 3501 | 0.190 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2018 | 32 | 0.190 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2019 | 58 | 0.190 |
Why?
| | Accidental Falls | 1 | 2020 | 153 | 0.190 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 66 | 0.190 |
Why?
| | Humans | 35 | 2021 | 113846 | 0.180 |
Why?
| | Complement Factor D | 1 | 2018 | 25 | 0.180 |
Why?
| | Gene Amplification | 1 | 2018 | 107 | 0.180 |
Why?
| | Infant Mortality | 1 | 2018 | 90 | 0.180 |
Why?
| | Sodium Bicarbonate | 1 | 2018 | 46 | 0.180 |
Why?
| | Potassium, Dietary | 1 | 2018 | 11 | 0.180 |
Why?
| | Regional Blood Flow | 1 | 2020 | 445 | 0.180 |
Why?
| | Propensity Score | 1 | 2019 | 226 | 0.180 |
Why?
| | Disease Progression | 6 | 2021 | 2489 | 0.180 |
Why?
| | Infant, Low Birth Weight | 1 | 2018 | 133 | 0.180 |
Why?
| | Sodium, Dietary | 1 | 2018 | 41 | 0.180 |
Why?
| | Metformin | 1 | 2021 | 290 | 0.180 |
Why?
| | Complement Factor B | 1 | 2018 | 99 | 0.170 |
Why?
| | Cell-Derived Microparticles | 1 | 2018 | 60 | 0.170 |
Why?
| | Death | 1 | 2018 | 89 | 0.170 |
Why?
| | Hyponatremia | 1 | 2018 | 48 | 0.170 |
Why?
| | Acidosis | 1 | 2018 | 97 | 0.170 |
Why?
| | Complement Pathway, Alternative | 1 | 2018 | 120 | 0.170 |
Why?
| | Calcitriol | 1 | 2017 | 50 | 0.170 |
Why?
| | Cholecalciferol | 1 | 2017 | 49 | 0.170 |
Why?
| | Blood Vessels | 1 | 2019 | 191 | 0.170 |
Why?
| | Antibodies | 1 | 2019 | 434 | 0.170 |
Why?
| | Thrombocytopenia | 1 | 2019 | 184 | 0.170 |
Why?
| | Adult | 16 | 2021 | 31979 | 0.170 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 255 | 0.170 |
Why?
| | Living Donors | 1 | 2018 | 202 | 0.170 |
Why?
| | Fructose | 1 | 2018 | 190 | 0.170 |
Why?
| | Pre-Eclampsia | 1 | 2018 | 171 | 0.160 |
Why?
| | Vascular Calcification | 1 | 2018 | 124 | 0.160 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 178 | 0.160 |
Why?
| | Peripheral Arterial Disease | 1 | 2021 | 312 | 0.150 |
Why?
| | Nitric Oxide | 1 | 2021 | 883 | 0.150 |
Why?
| | Glioma | 1 | 2018 | 274 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2016 | 136 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 694 | 0.140 |
Why?
| | Oxidative Stress | 1 | 2021 | 1244 | 0.140 |
Why?
| | Dietary Supplements | 1 | 2017 | 436 | 0.130 |
Why?
| | Longitudinal Studies | 5 | 2020 | 2692 | 0.130 |
Why?
| | Kidney Diseases | 1 | 2017 | 396 | 0.130 |
Why?
| | Complement Activation | 3 | 2021 | 333 | 0.120 |
Why?
| | Interleukin-1 | 1 | 2017 | 1049 | 0.120 |
Why?
| | Healthcare Disparities | 1 | 2017 | 465 | 0.120 |
Why?
| | Enzyme Inhibitors | 1 | 2016 | 945 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2021 | 3369 | 0.110 |
Why?
| | Tooth Loss | 1 | 2011 | 33 | 0.110 |
Why?
| | Health Services Accessibility | 1 | 2017 | 777 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2018 | 960 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2019 | 4906 | 0.110 |
Why?
| | Time Factors | 5 | 2021 | 7060 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1136 | 0.110 |
Why?
| | Risk Factors | 6 | 2021 | 9050 | 0.100 |
Why?
| | Vitamin D | 3 | 2018 | 329 | 0.100 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2828 | 0.100 |
Why?
| | Liver | 1 | 2018 | 1867 | 0.100 |
Why?
| | Risk Assessment | 4 | 2021 | 3147 | 0.100 |
Why?
| | Cross-Sectional Studies | 4 | 2020 | 4275 | 0.090 |
Why?
| | Independent Living | 2 | 2018 | 69 | 0.090 |
Why?
| | Prognosis | 3 | 2021 | 3544 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 1711 | 0.090 |
Why?
| | Parathyroid Hormone | 2 | 2018 | 113 | 0.080 |
Why?
| | Young Adult | 5 | 2021 | 10971 | 0.080 |
Why?
| | Self Report | 1 | 2011 | 684 | 0.080 |
Why?
| | Intensive Care Units | 2 | 2021 | 585 | 0.080 |
Why?
| | Pregnancy Outcome | 2 | 2018 | 343 | 0.080 |
Why?
| | Brain | 1 | 2018 | 2686 | 0.070 |
Why?
| | Inflammation Mediators | 2 | 2019 | 556 | 0.070 |
Why?
| | Obesity | 1 | 2017 | 2627 | 0.070 |
Why?
| | United States | 5 | 2019 | 12329 | 0.070 |
Why?
| | Pilot Projects | 2 | 2018 | 1421 | 0.070 |
Why?
| | Incidence | 2 | 2021 | 2470 | 0.060 |
Why?
| | Sex Factors | 2 | 2020 | 1997 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2021 | 9002 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2021 | 4429 | 0.060 |
Why?
| | Cohort Studies | 3 | 2018 | 5011 | 0.060 |
Why?
| | Antibody Specificity | 1 | 2021 | 198 | 0.060 |
Why?
| | Minerals | 1 | 2020 | 35 | 0.050 |
Why?
| | Prevalence | 2 | 2018 | 2407 | 0.050 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2019 | 47 | 0.050 |
Why?
| | Pulse Wave Analysis | 1 | 2020 | 162 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2019 | 58 | 0.050 |
Why?
| | Acute-Phase Proteins | 1 | 2019 | 69 | 0.050 |
Why?
| | Matched-Pair Analysis | 1 | 2019 | 45 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2018 | 6796 | 0.050 |
Why?
| | Allografts | 1 | 2019 | 106 | 0.050 |
Why?
| | Complement C4a | 1 | 2018 | 10 | 0.050 |
Why?
| | Mice | 3 | 2020 | 15641 | 0.050 |
Why?
| | Colorado | 2 | 2021 | 4581 | 0.050 |
Why?
| | Biological Availability | 1 | 2018 | 159 | 0.050 |
Why?
| | Half-Life | 1 | 2018 | 187 | 0.050 |
Why?
| | Feasibility Studies | 1 | 2021 | 739 | 0.050 |
Why?
| | Complement C5a | 1 | 2018 | 60 | 0.050 |
Why?
| | Hepatocytes | 1 | 2019 | 203 | 0.050 |
Why?
| | Complement Membrane Attack Complex | 1 | 2018 | 34 | 0.050 |
Why?
| | Clone Cells | 1 | 2018 | 261 | 0.050 |
Why?
| | African Americans | 2 | 2017 | 1101 | 0.050 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2019 | 185 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 145 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2019 | 222 | 0.050 |
Why?
| | Transplantation, Homologous | 1 | 2019 | 490 | 0.050 |
Why?
| | Healthy Aging | 1 | 2018 | 18 | 0.040 |
Why?
| | Fathers | 1 | 2018 | 47 | 0.040 |
Why?
| | Ligands | 1 | 2019 | 532 | 0.040 |
Why?
| | Area Under Curve | 1 | 2018 | 328 | 0.040 |
Why?
| | TRPP Cation Channels | 1 | 2018 | 67 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2018 | 416 | 0.040 |
Why?
| | Child | 3 | 2021 | 17711 | 0.040 |
Why?
| | Animals | 4 | 2020 | 35394 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2018 | 5080 | 0.040 |
Why?
| | ROC Curve | 1 | 2018 | 488 | 0.040 |
Why?
| | Waiting Lists | 1 | 2017 | 131 | 0.040 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 676 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2018 | 484 | 0.040 |
Why?
| | Congenital Abnormalities | 1 | 2017 | 68 | 0.040 |
Why?
| | Organ Size | 1 | 2017 | 499 | 0.040 |
Why?
| | Body Mass Index | 2 | 2017 | 2098 | 0.040 |
Why?
| | Adolescent | 3 | 2021 | 18736 | 0.040 |
Why?
| | Graft Rejection | 1 | 2019 | 572 | 0.040 |
Why?
| | Pregnancy | 2 | 2018 | 5290 | 0.040 |
Why?
| | Administration, Oral | 1 | 2018 | 798 | 0.040 |
Why?
| | Cerebrovascular Circulation | 1 | 2018 | 186 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3049 | 0.040 |
Why?
| | Biopsy | 1 | 2019 | 1065 | 0.040 |
Why?
| | Neuroimaging | 1 | 2018 | 210 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2019 | 716 | 0.040 |
Why?
| | Nutritional Status | 1 | 2018 | 282 | 0.040 |
Why?
| | Survival Analysis | 1 | 2019 | 1414 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2018 | 872 | 0.040 |
Why?
| | Up-Regulation | 1 | 2019 | 975 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2019 | 798 | 0.040 |
Why?
| | Premature Birth | 1 | 2017 | 219 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 526 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 776 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2115 | 0.030 |
Why?
| | Glucose | 1 | 2018 | 887 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 604 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2025 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1854 | 0.030 |
Why?
| | Overweight | 1 | 2017 | 472 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2020 | 11340 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1302 | 0.030 |
Why?
| | Proteomics | 1 | 2018 | 772 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2893 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2018 | 1095 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 593 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3330 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 2074 | 0.030 |
Why?
| | Autoantibodies | 1 | 2019 | 1222 | 0.030 |
Why?
| | Cytokines | 1 | 2019 | 1981 | 0.030 |
Why?
| | Income | 1 | 2011 | 165 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2011 | 146 | 0.030 |
Why?
| | Mental Recall | 1 | 2011 | 216 | 0.020 |
Why?
| | Social Class | 1 | 2011 | 222 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3910 | 0.020 |
Why?
| | Blood Glucose | 1 | 2018 | 1940 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 409 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 363 | 0.020 |
Why?
| | Rats | 1 | 2018 | 6387 | 0.020 |
Why?
| | Learning | 1 | 2011 | 373 | 0.020 |
Why?
| | Infant | 1 | 2018 | 8090 | 0.020 |
Why?
| | Stroke | 1 | 2011 | 930 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 969 | 0.020 |
Why?
| | Smoking | 1 | 2011 | 1632 | 0.020 |
Why?
| | Depression | 1 | 2011 | 1129 | 0.010 |
Why?
|
|
You's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|